Document ID: chunk:federal_register_of_legislation:F2024L01389:schedule:1:p51
Version: federal_register_of_legislation:F2024L01389
Segment Type: schedule
Provision Reference: sch 1 (pt 51/66)
Character Range: 152482–157907

a medical practitioner, (ii) an authorised PBS prescriber who is not a medical practitioner, but who is: (a) sharing care of the patient with at least one medical practitioner; (b) intending to share care of the patient with a medical practitioner.
C16035  P16035  CN16035  Itraconazole                 Systemic histoplasmosis                                                                                                                                                                                                                                                                                                                                                                                             Compliance with Authority Required procedures - Streamlined Authority Code 16035
                                                      Must be treated by a health practitioner who is any of: (i) a medical practitioner, (ii) an authorised PBS prescriber who is not a medical practitioner, but who is: (a) sharing care of the patient with at least one medical practitioner; (b) intending to share care of the patient with a medical practitioner.
C16037  P16037  CN16037  Rifampicin                   Haemophilus influenzae type B
                                                      The treatment must be for prophylaxis; AND
                                                      Patient must be in contact with people who have the disease; AND
                                                      Must be treated by a health practitioner who is any of: (i) a medical practitioner, (ii) an authorised PBS prescriber who is not a medical practitioner, but who is: (a) sharing care of the patient with at least one medical practitioner; (b) intending to share care of the patient with a medical practitioner.
C16042  P16042  CN16042  Voriconazole                 Definite or probable invasive aspergillosis                                                                                                                                                                                                                                                                                                                                                                         Compliance with Authority Required procedures
                                                      Treatment and maintenance therapy
                                                      Patient must be immunocompromised; AND
                                                      Must be treated by a health practitioner who is any of: (i) a medical practitioner, (ii) an authorised PBS prescriber who is not a medical practitioner, but who is: (a) sharing care of the patient with at least one medical practitioner; (b) intending to share care of the patient with a medical practitioner.
C16043  P16043  CN16043  Rifampicin                   Mycobacterium ulcerans infection (Buruli ulcer)                                                                                                                                                                                                                                                                                                                                                                     Compliance with Authority Required procedures
                                                      The treatment must be used in combination with another antibiotic for the treatment of Buruli ulcer; AND
                                                      Must be treated by a health practitioner who is any of: (i) a medical practitioner, (ii) an authorised PBS prescriber who is not a medical practitioner, but who is: (a) sharing care of the patient with at least one medical practitioner; (b) intending to share care of the patient with a medical practitioner.
C16048  P16048  CN16048  Risperidone                  Severe behavioural disturbances                                                                                                                                                                                                                                                                                                                                                                                     Compliance with Authority Required procedures - Streamlined Authority Code 16048
                                                      Continuing treatment
                                                      Patient must have autism spectrum disorder; AND
                                                      Patient must have been commenced on PBS-subsidised treatment with risperidone prior to turning 18 years of age; AND
                                                      The treatment must be under the supervision of a paediatrician or psychiatrist; AND
                                                      The treatment must be in combination with non-pharmacological measures;
                                                      Patient must be at least 18 years of age.
                                                      Behaviour disturbances are defined as severe aggression and injuries to self or others where non-pharmacological methods alone have been unsuccessful.
                                                      The diagnosis of autism spectrum